Press Releases

 Filter by Provider

Sunoco LP (TXSE: SUN) (“SUN” or the “Partnership”) and SunocoCorp LLC (TXSE: SUNC) ("SUNC") today reported financial and operating results for the quarter ended September 30, 2026.

Cross Country Healthcare today announced the appointments of Susana E. Pichardo as Chief Financial Officer and Andrew Harris as Chief Transformation Officer, both reporting to Chief Executive Officer Joel Tremblay. The appointments strengthen the executive leadership team as the company invests in financial leadership and enterprise transformation to advance its growth strategy.

Energy Transfer LP (TXSE:ET) (“Energy Transfer” or the “Partnership”) today reported financial results for the quarter ended September 30, 2026.

Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced financial results for the quarter ended September 30, 2026, and highlighted recent corporate accomplishments and 2026 milestones.

Tradeweb Markets Inc. (Nasdaq: TW), a global leader in electronic trading across asset classes, today announced the launch of Muni Sweep, a session-based trading protocol for the municipal bond market.

The Real Brokerage Inc., a leading technology-enabled real estate platform redefining the industry through innovation and agent culture, today announced that Cody Burger and Dennis Buchheit are bringing their 30-agent real estate brokerage, previously operating as Unlimited, to the company under the name The Team.

PETAH TIKVA, Israel, Nov. 03, 2026 (GLOBE NEWSWIRE) -- TurboGen Ltd. (NASDAQ:TRBG) (TASE:TURB) (“TurboGen” or the “Company”), a developer of combined heat and power systems based on multifuel microturbines, today announces that it has completed the first assembly of its propriety TR2000 system, a 20 kilowatt (“kW”) unit designed for defense applications as well as residential buildings and other civilian projects. Upon completion of the TR2000 system’s assembly, the Company began testing the system internally.

PALO ALTO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, announced today that two moderated posters and three posters on acoramidis and transthyretin amyloid cardiomyopathy (ATTR-CM), along with one BridgeBio-supported poster presentation led by Abbott Laboratories, will be shared at the American Heart Association (AHA) Scientific Sessions 2026, taking place in Chicago, Illinois on November 6-9, 2026. The data further strengthen the differentiated clinical profile of acoramidis, reinforcing it as the first-line treatment of choice for individuals with ATTR-CM. Acoramidis is the only selective small molecule, orally administered, near-complete (≥90%) transthyretin (TTR) stabilizer.

IMS Legal Strategies (IMS) announces a new expansion of its fast-growing Life Care Planning services and a continuation of its overall growth strategy, with the acquisition of Medical & Life Care Consulting Services (MLCC), the well-established, multi-discipline firm based in Massachusetts that works throughout New England and nationally. All members of the MLCC team will join IMS.

Progentos Therapeutics, a biotechnology company developing regenerative medicines for multiple sclerosis (MS) and other demyelinating diseases, today announced that the first participant has been dosed in its Phase 1/2a clinical trial of PRO-1562 (NCT07826689). PRO-1562 is a novel oral small molecule designed to regenerate myelin in patients with demyelinating diseases, like MS, with the potential to protect neuroaxonal integrity and restore neurologic function.

LOUISVILLE, Ky., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ: CREX), a leading provider of digital signage and media solutions, announced today that it will release its financial results for the three months ended September 30, 2026 before the market open on Monday, November 16, 2026. A conference call to review the results is scheduled for Monday, November 16, 2026, at 9:00 am Eastern Time, which will include prepared remarks and materials from management followed by a live Q&A. The call will be hosted by Rick Mills, Chairman and Chief Executive Officer, Tamra Koshewa, Chief Financial Officer and George Sautter, Chief Strategy Officer.

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the following conferences:

CEO Michael Halstead to participate in a fireside chat on November 9, 2026 at 3:00 p.m. EDT

IRVINE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will participate at upcoming investor conferences:

Decades of experience growing dual-use defense technology companies 

WAYNE, Pa., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella or the “Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies for serious, rare skin diseases and vascular anomalies for which there are no U.S. Food and Drug Administration (FDA)-approved therapies, today announced that members of its management team will present at the Stifel 2026 Healthcare Conference on Tuesday, November 10, 2026, at 9:20 a.m. ET.

Starting November 4, MyHabit members can order $2 drinks, $4 Santa Barbara Loaded Fries and $6 BBQ Tossed Crispy Chicken Bites exclusively through Habit’s digital ordering channels

IMS Legal Strategies (IMS) announces a new expansion of its fast-growing services, and a continuation of its overall growth strategy, with the acquisition of Medical & Life Care Consulting Services (MLCC), the well-established, multi-discipline firm based in Massachusetts that works throughout New England and nationally. All members of the MLCC team will join IMS.

New patient pathway places greater emphasis on personalised hairline design, clinical suitability and individual treatment goals as demand for gender-specific hair restoration grows

Bethlehem, Pennsylvania - November 3, 2026 - Soltech, the Bethlehem, Pennsylvania–based designer of grow lights for the home, today announced that the re-engineered Aura™ Ambient Grow Light is now available for pre-order at soltech.com. Priced at $250, the new Aura is estimated to ship in February 2027.

Nuveen Churchill Direct Lending Corp. (NYSE: NCDL) (“NCDL” or the “Company”), a business development company externally managed by its investment adviser, Churchill DLC Advisor LLC (the “Adviser”), and by its sub-adviser, Churchill Asset Management LLC (“Churchill”), today reported financial results for the third quarter ended September 30, 2026.

Connecting Corporate News with North America's Media Landscape

Tel Aviv, Israel, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Nexera Technologies Ltd (“Nexera” or the “Company”) (Nasdaq: NEXR, NEXRW), today announced that, as previously announced by its subsidiary, Fort Technology Inc. (Nasdaq: FRTT, TSXV: FORT) (“Fort”), the TSX Venture Exchange ("TSXV") has approved the voluntary delisting of Fort’s common shares from the TSXV. The voluntary delisting from the TSXV will not affect the listing of the Fort’s common shares on the Nasdaq Capital Market (the "Nasdaq"), which will continue to trade on the Nasdaq under the symbol FRTT.

Lead pan-coronavirus program expected to file CTA/IND in 2H 2027Optimized lead candidate shows potential for once-weekly dosing in preclinical studiesCash on balance sheet of $8.1 million at September 30, 2026

Solen Software Group, a permanent capital partner to mission-critical software companies, today announced an investment partnership with Teletask Inc., the two-way messaging platform that WIC (Special Supplemental Nutrition Program for Women, Infants, and Children) and public health agencies use to reach families by text, voice, and email. Teletask supports public health agencies in more than 35 states, including WIC agencies serving over three million participants, and delivers more than 100 million messages a year.

WALTHAM, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced that Ron Renaud, President and Chief Executive Officer, and additional members of the management team will participate in the following investor conferences:

EDMONTON, Alberta, Nov. 3, 2026 (SEND2PRESS NEWSWIRE) -- What if the rapid advancement of artificial intelligence could help us ask some of humanity's oldest questions in a new way? In "The Infinity Formula: How Consciousness, AI, and Time Lead Us Back to the Source" (ISBN: 978-1834383446; released through Tellwell Publishing), author Calvin Engen explores the relationship between consciousness, time, technological acceleration, and the human search for meaning.

Englewood, Florida - November 03, 2026 - Vellum and Gilt Art, a hand-curated online art shop offering framed prints, original paintings, and vintage finds, has launched its See It On Your Wall visualization feature, enabling site visitors to preview any piece of artwork on their own wall before making a purchase. The tool is now live across the entire catalog at VellumAndGiltArt.com.

Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons who purchased or otherwise acquired Gildan Activewear Inc. (NYSE: GIL) securities between February 19, 2025 and June 15, 2026, inclusive (the “Class Period”). Gildan describes itself as "a leading vertically integrated manufacturer of everyday basic apparel, including activewear, underwear, and hosiery products."

CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced the publication of a new analysis from the Kidney Allograft Outcomes AlloSure Registry (KOAR), a landmark multicenter study, in the journal Transplantation.

Elucid, an innovator of AI-powered cardiovascular imaging software, today announced results from ELUCIDATE, presented at the annual Transcatheter Cardiovascular Therapeutics Conference (TCT 2026). The ELUCIDATE study, which supported Elucid’s recent U.S. Food and Drug Administration (FDA) 510(k) clearance of the FFR-IQTM software, demonstrated 92.9 percent vessel-level diagnostic accuracy for Elucid’s FFR-IQ technology versus invasive fractional flow reserve (FFR). ELUCIDATE also demonstrated high accuracy in the “gray zone,” FFR values between 0.75 and 0.85, which represent a physiological area of uncertainty when evaluating moderate stenosis.

Everforth™ ECS®, a trusted mission operations partner for defense, intelligence, and federal civilian agencies, and the Federal Government Segment of Everforth, Inc. (NYSE: EFOR), today announced it has secured an up to two-year prime contract extension with the National Geospatial-Intelligence Agency (NGA). The extension has a potential value of more than $200 million.

Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter ended September 30, 2026. To view the detailed third quarter 2026 earnings press release and presentation, please visit the company’s investor relations website at https://investor.alkermes.com.

NORTH BETHESDA, Md., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Xometry, Inc. (NASDAQ: XMTR), the global AI-native marketplace connecting buyers and suppliers of custom manufacturing, today announced its financial results for the third quarter ended September 30, 2026.

New research from MIT Sloan School of Management and MIT FutureTech suggests that the public, investors, and regulators lack information about whether companies are prepared for AI risks.

A still that goes out with a company release used to mean a reshoot when one label, one line of type, or one prop was wrong. The page for the next image editor describes a narrower change. You lay a mark on the picture, say what should change, and leave…

Upstart Holdings, Inc. (NASDAQ: UPST), the leading artificial intelligence (AI) lending marketplace, today published its monthly origination volume for October 2026 along with the latest Upstart Macro Index (UMI) reading. For historical data and more information, see upstart.com/volume and upstart.com/umi.

Sophia Learning, an online, on-demand, self-paced learning platform offering courses recommended for college-level credit by ACE®, today announced a new partnership with Rocky Mountain College of Art + Design (RMCAD). Through this partnership, RMCAD, a Denver-area college focused on art and design education, joins Sophia Learning’s growing network of partner colleges and universities, providing eligible students with a flexible pathway to complete select general education coursework.

Operating cash use about 5% of net sales, down from 66% in Q2 and 249% in Q1; B2B and distribution reached 50% of September net salesNinth consecutive month of net sales growth; September sets Company record at $2.68 million

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today reported financial results for the third quarter ended September 30, 2026, and provided a business update.

NEW HAVEN, Conn., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on November 1, 2026, Invivyd granted seven newly hired non-executive employees options to purchase an aggregate of 175,000 shares of its common stock, each as a material inducement for each employee’s entry into employment with Invivyd. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4) and pursuant to the Invivyd, Inc. 2026 Inducement Plan. 

Definium Therapeutics, Inc. (Nasdaq: DFTX) ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company’s management team will participate in the following investor conferences:

CINCINNATI, Ohio, and TALLAHASSEE, Fla., Nov. 3, 2026 (SEND2PRESS NEWSWIRE) -- Chase Doors, A Senneca Brand, is proud to announce that its ColdGuard® Gen II Swing Door has received Florida Building Code (FBC) Product Approval, validating the door's compliance with the Florida Building Code's stringent requirements for structural integrity, wind resistance, and impact performance.

ATLANTA, Ga., Nov. 3, 2026 (SEND2PRESS NEWSWIRE) -- Down Payment Resource (DPR), the housing industry's leading affordability intelligence platform, today announced that Angel Romero, housing finance agency relationship manager at DPR, has been named vice chair of the Technology Impact and Enablement (TIE) Community of Practice at the Mortgage Industry Standards Maintenance Organization (MISMO®). The community brings together stakeholders from across the mortgage industry to identify, evaluate and advance technology innovations and to assess how emerging technologies affect mortgage processes, data standards and interoperability.

DALLAS, TX / ACCESS Newswire / November 3, 2026 / Fermi Inc. (NASDAQ:FRMI)(LSE:FRMI), operating as Fermi America™ ("Fermi" or the "Company"), today issued the following statement on the Data Center Lease and Services Agreement (the "Lease") between its wholly owned subsidiary, Fermi Campus 1 LLC, and TensorWave TEX1, LLC ("TensorWave"), after the October 31, 2026 closing date passed without extension.

Company to evaluate existing U.S. power infrastructure and data center operations for potential AI infrastructure hosting opportunities

Experienced capital markets and corporate development executive brings extensive public-company, financing and strategic transaction experience to INEO

Landmark industry-first certification reinforces ZEO's leadership in manufacturing quality, independent oversight, and the rapidly expanding U.S. regenerative medicine industry.

Investor Conference Call to be conducted on the same day at 4:30 p.m. Eastern

Paywow offers expanded payroll capabilities, flexible subscription options and affordable pricing for businesses across industries.